JP2024511079A5 - - Google Patents
Info
- Publication number
- JP2024511079A5 JP2024511079A5 JP2023557734A JP2023557734A JP2024511079A5 JP 2024511079 A5 JP2024511079 A5 JP 2024511079A5 JP 2023557734 A JP2023557734 A JP 2023557734A JP 2023557734 A JP2023557734 A JP 2023557734A JP 2024511079 A5 JP2024511079 A5 JP 2024511079A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amino acid
- composition according
- acid sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163161758P | 2021-03-16 | 2021-03-16 | |
| US63/161,758 | 2021-03-16 | ||
| PCT/US2022/020385 WO2022197703A1 (en) | 2021-03-16 | 2022-03-15 | Wound healing enhancement with anti-ceramide antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511079A JP2024511079A (ja) | 2024-03-12 |
| JP2024511079A5 true JP2024511079A5 (enExample) | 2025-09-03 |
Family
ID=83321040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557734A Pending JP2024511079A (ja) | 2021-03-16 | 2022-03-15 | 抗セラミド抗体による創傷治癒の強化 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240158487A1 (enExample) |
| EP (1) | EP4308231A4 (enExample) |
| JP (1) | JP2024511079A (enExample) |
| KR (1) | KR20230162788A (enExample) |
| CN (1) | CN117320750A (enExample) |
| BR (1) | BR112023018758A2 (enExample) |
| CA (1) | CA3212333A1 (enExample) |
| IL (1) | IL305920A (enExample) |
| MX (1) | MX2023010858A (enExample) |
| WO (1) | WO2022197703A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2152287B1 (en) * | 2007-05-06 | 2014-04-02 | Sloan Kettering Institute For Cancer Research | Methods for treating and preventing gi syndrome and graft versus host disease |
| WO2010027802A2 (en) * | 2008-08-25 | 2010-03-11 | New York University | Methods for treating diabetic wounds |
| CA3172599C (en) * | 2012-05-25 | 2025-10-07 | Sloan Kettering Institute For Cancer Research | ANTI-CERAMID ANTIBODY AND RELATED ANTIGEN BINDING FRAGMENT |
| US10450385B2 (en) * | 2014-08-07 | 2019-10-22 | Memorial Sloan Kettering Cancer Center | Anti-ceramide antibodies |
| EP4121110A4 (en) * | 2020-03-18 | 2024-06-12 | Memorial Sloan Kettering Cancer Center | ANTI-CERAMIDE ANTIBODIES |
-
2022
- 2022-03-15 JP JP2023557734A patent/JP2024511079A/ja active Pending
- 2022-03-15 WO PCT/US2022/020385 patent/WO2022197703A1/en not_active Ceased
- 2022-03-15 CA CA3212333A patent/CA3212333A1/en active Pending
- 2022-03-15 EP EP22772059.6A patent/EP4308231A4/en active Pending
- 2022-03-15 CN CN202280032286.4A patent/CN117320750A/zh active Pending
- 2022-03-15 MX MX2023010858A patent/MX2023010858A/es unknown
- 2022-03-15 IL IL305920A patent/IL305920A/en unknown
- 2022-03-15 BR BR112023018758A patent/BR112023018758A2/pt unknown
- 2022-03-15 KR KR1020237035170A patent/KR20230162788A/ko active Pending
- 2022-03-15 US US18/550,933 patent/US20240158487A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515271A5 (enExample) | ||
| JP2021526022A5 (enExample) | ||
| JP2021524256A5 (enExample) | ||
| RU2013155906A (ru) | Антитела анти-angptl3 и их применение | |
| JP2021526534A5 (enExample) | ||
| RU2009120052A (ru) | Композиции и способы связывания сфингозин-1-фосфата | |
| RU2014148502A (ru) | Человеческие антитела к fel d1 и способы их применения | |
| JP2013542194A5 (enExample) | ||
| RU2012131547A (ru) | Антитела человека против ангиопоэтин-подобного белка 4 человека | |
| JP2015503909A5 (enExample) | ||
| RU2016118769A (ru) | Способы лечения состояний, ассоциированных с masp-2-зависимой активацией комплемента | |
| RU2019139093A (ru) | Фармацевтическая композиция на основе антитела к pd-l1 и ее применение | |
| CN104684552A (zh) | 组合及其用途 | |
| JP2023534214A5 (enExample) | ||
| JP2023545183A5 (enExample) | ||
| RU2017144629A (ru) | Тромбин-связывающие молекулы антител и их применение | |
| JP2019528046A5 (enExample) | ||
| JP2024516698A5 (enExample) | ||
| RU2018129180A (ru) | Тромбиновое антитело, антиген-связывающий фрагмент и их фармацевтическое применение | |
| JP2021523138A5 (enExample) | ||
| JP2023502398A5 (enExample) | ||
| JP2023537078A5 (enExample) | ||
| TWI834254B (zh) | α-烯醇酶拮抗劑治療纖維化疾病之用途 | |
| JP2021529766A5 (enExample) | ||
| JP2024511853A5 (enExample) |